Synthesis of Neolamellarin A, an Inhibitor of Hypoxia-inducible Factor-1

被引:0
作者
Arafeh, Khaled M. [1 ]
Ullah, Nisar [1 ]
机构
[1] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia
关键词
hypoxia-inducible factor-1; antitumor agent; acylation; natural product; HIF-1; BLOCKADE; THERAPY; CANCER;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Neolamellarin A, a metabolite isolated from the sponge Dendrilla nigra, was found to inhibit hypoxia-inducible factor-1 (HIF-1) activation by 26% at 10 mu M concentration and inhibition of HIF-1 has become a major antitumour molecular target. Herein the first synthesis of neolamellarin A is described. The synthetic strategy features the condensation of vinylogous amide with aminomalonate to construct the 3,4-bis(4-methoxyphenyl)-1H-pyrrole core and the subsequent acylation and deprotection rendered the target compound in 18% over all yield.
引用
收藏
页码:925 / 926
页数:2
相关论文
共 10 条
[1]   Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway [J].
Kung, AL ;
Zabludoff, SD ;
France, DS ;
Freedman, SJ ;
Tanner, EA ;
Vieira, A ;
Cornell-Kennon, S ;
Lee, J ;
Wang, BQ ;
Wang, JM ;
Memmert, K ;
Naegeli, HU ;
Petersen, F ;
Eck, MJ ;
Bair, KW ;
Wood, AW ;
Livingston, DM .
CANCER CELL, 2004, 6 (01) :33-43
[2]  
MICHAEL S, 2008, ARCH PHARM, V341, P281
[3]   Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity [J].
Moeller, BJ ;
Dreher, MR ;
Rabbani, ZN ;
Schroeder, T ;
Cao, YT ;
Li, CY ;
Dewhirst, MW .
CANCER CELL, 2005, 8 (02) :99-110
[4]  
NOBORU O, 1998, J CHEM SOC P1, P1595
[5]  
RUI L, 2007, J NAT PRODUCTS, V70, P1741
[6]  
SANGHEE K, 2001, B KOREAN CHEM SOC, V22, P1403
[7]   Development of novel therapeutic strategies that target HIF-1 [J].
Semenza, GL .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (02) :267-280
[8]   Targeting HIF-1 for cancer therapy [J].
Semenza, GL .
NATURE REVIEWS CANCER, 2003, 3 (10) :721-732
[9]   The hypoxia-inducible factor-1α is a negative factor for tumor therapy [J].
Unruh, A ;
Ressel, A ;
Mohamed, HG ;
Johnson, RS ;
Nadrowitz, R ;
Richter, E ;
Katschinski, DM ;
Wenger, RH .
ONCOGENE, 2003, 22 (21) :3213-3220
[10]   Hypoxia in cancer: significance and impact on clinical outcome [J].
Vaupel, Peter ;
Mayer, Arnulf .
CANCER AND METASTASIS REVIEWS, 2007, 26 (02) :225-239